VIRACTA
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90419851
- Registration number
- 6726144
- Mark type
- Stylized text
- Filed
- 28 Dec 2020
- Published for opposition
- 03 Aug 2021
- Registered
- 24 May 2022
- Attorney of record
- Alyssa M. Worsham
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies
Owner
- Viracta Therapeutics, Inc., Cardiff, CA, US
- Viracta Therapeutics, Inc., Cardiff, CA, US
- Viracta Therapeutics, Inc., Cardiff, CA, US
Prosecution history
- 29 Jan 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Apr 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Apr 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Mar 2022 — USE AMENDMENT FILED
- 23 Mar 2022 — SOU EXTENSION 1 GRANTED
- 15 Mar 2022 — SOU EXTENSION 1 FILED
- 23 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Mar 2022 — TEAS STATEMENT OF USE RECEIVED
- 28 Sept 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED